April 16, 2014
The Eighth Circuit on Tuesday refused to rehear en banc a ruling that cleared Eli Lilly & Co. of failing to warn that long-term users of the antipsychotic drug Zyprexa risk developing an involuntary movement disorder.
March 10, 2014
The Eighth Circuit on Monday upheld a victory for Eli Lilly & Co. in a lawsuit claiming it failed to adequately warn of the risks of long-term use of the antipsychotic drug Zyprexa, backing a lower court's exclusion of expert testimony.